Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a devastating disease with high morbidity and mortality. Deleterious remodeling in the pulmonary arterial system leads to irreversible arterial constriction and elevated pulmonary arterial pressures, right heart failure, and eventually death. The difficulty i...
Main Authors: | Gabriel Redel-Traub, Kevin J. Sampson, Robert S. Kass, Michael S. Bohnen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/10/1341 |
Similar Items
-
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
by: Hélène Le Ribeuz, et al.
Published: (2020-09-01) -
The Impact of Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery
by: Michael S. Bohnen, et al.
Published: (2017-09-01) -
Up-regulated expression of two-pore domain K+ channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension
by: Natsumi Shima, et al.
Published: (2024-02-01) -
Identification of the Involvement of Potassium Channels in Fibromyalgia
by: Kim Lawson
Published: (2022-10-01) -
Negative Influence by the Force: Mechanically Induced Hyperpolarization via K<sub>2P</sub> Background Potassium Channels
by: Miklós Lengyel, et al.
Published: (2021-08-01)